Trump Says He’ll Sign Order That Will Cut Drug Prices By ‘30% To 80%’
By: bitcoin ethereum news|2025/05/12 16:00:13
0
Share
Topline President Donald Trump will sign an executive order on Monday that will require pharmaceutical companies to price prescription drugs in the U.S. the same as the lowest price they charge in other countries, in a move the president claims will reduce prescription drug prices “by 30% to 80%.” US President Donald Trump will sign an executive order on Monday that he says will significantly ... More lower drug prices in the U.S. Key Facts In a post on his Truth Social platform, Trump said his executive order will institute a “MOST FAVORED NATION’S POLICY” where the U.S. will pay the same price for a drug as the “Nation that pays the lowest price anywhere in the World.” In his post, the President called out the fact that prescription drug prices in the U.S. were several times higher than those in other countries and said “the ‘suckers’ of America” were being forced to bear drugmakers’ claimed research and development costs “ALONE.” Trump claimed his order would bring prescription drug prices in the U.S. down “almost immediately, by 30% to 80%” but go up elsewhere in the World, “in order to equalize and...bring FAIRNESS TO AMERICA!” A few hours before making the post, the president teased the announcement, saying his next Truth Social post “will be one of the most important and impactful I have ever issued.” The post did not specify how his administration would implement the plan or how it would impact the cost of Medicare and Medicaid drugs. Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you’ll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here . How Much More Do Americans Spend On Prescription Drugs Compared Others? A 2024 study published by RAND found that across all drugs, U.S. prices were nearly 2.8 times higher than those in other countries. When only “brand-name originator drugs” were considered, prices in the U.S. were more than 4.2 times higher compared to other countries. The study evaluated drug prices in 32 of the 38 advanced economies in the Organization for Economic Co-operation and Development (OECD). The report noted that Americans paid 33% less for unbranded, generic drugs than other countries in the study. However, this did not offset the high spending on brand-name drugs, as generics made up only 8% of overall prescription spending despite making up 90% of filled prescriptions in the U.S. Another analysis of spending on prescription medicine in OECD countries published by Peterson-KFF Health System Tracker in 2022, also showed significantly higher spending by Americans. The study showed that Americans spent $1,126 per capita on prescription drugs while other developed countries spent around $552 per capita. The analysis included both out of pocket spending and prices paid by insurers. Crucial Quote In his post Trump wrote: “The Pharmaceutical/Drug Companies would say, for years, that it was Research and Development Costs, and that all of these costs were, and would be, for no reason whatsoever, borne by the “suckers” of America, ALONE. Campaign Contributions can do wonders, but not with me, and not with the Republican Party. We are going to do the right thing, something that the Democrats have fought for many years.” What To Watch For The ‘Most Favored Nation’ proposal will likely face strong push back and legal challenges from drug makers, who have argued for years that capping prices will impact innovation and slow development of new drugs. Alex Schriver, an official from the Pharmaceutical Research and Manufacturers of America (PhRMA)—the trade body group that represents drug makers—told the New York Times: “Government price setting in any form is bad for American patients. Policymakers should focus on fixing the flaws in the U.S. system, not importing failed policies from abroad.” Further Reading Trump promises to order that the US pay only the price other nations do for some drugs (Associated Press) Trump Plan Would Tie Some Drug Prices to What Peer Nations Pay (New York Times) Source: https://www.forbes.com/sites/siladityaray/2025/05/12/trump-says-he-will-sign-executive-order-to-cut-drug-prices-by-30-to-80-what-to-know/
You may also like

Stablecoins Finally Find Real Returns: On-Chain Reinsurance Re Explained | Interview with Re Founder Karan Saroya
This on-chain reinsurance platform absorbs stablecoins from DeFi, uses them as collateral to underwrite for American insurance companies, collects premiums, and returns the profits to on-chain depositors.

The AI gamble of mining companies: Valuations enter a phase of differentiation, and it's hard to turn the tide
This gamble of transforming into AI is testing the financial strength and execution capability of mining companies.

A letter from Alliance to entrepreneurs: Written on the occasion of Cursor selling for 60 billion dollars
Great companies are forged before they become obvious.

Will MicroStrategy fall into a death spiral? What will the macro trend be in the second half of the year?
The cryptocurrency industry may gradually shift from the hype of native altcoins to real asset tokenization, on-chain machine economy, and a more mature industrialization phase.

Blockchain Capital Partner: The Core Secret of Arbitrage
On cold starts, breaking the circle, and the toughest hurdle for founders to overcome.

STRC unanchored by 11%, can the perpetual motion machine of Strategy still operate?
Beyond the leverage crunch, what is even more concerning is the liquidity reserves of the Strategy.

Bitcoin Market Analysis 2026: Can BTC Reach $150K by Year-End?
Bitcoin price prediction 2026: Can BTC hit $150,000 by year-end? Explore Fed policy, Kevin Warsh's stance, Bitcoin ETF flows, exchange data, and BTC market forecasts.

Bitcoin ETF Outflows Hit a Record $4.4 Billion: What Are Traders Doing With Their Cash?
Bitcoin ETFs lost $4.4 billion over 13 trading days, raising questions about market sentiment and Bitcoin's bottom. Here's what Standard Chartered is watching and how traders are managing idle stablecoin balances during uncertain markets.

WEEX App Just Got Smarter – New Tabs for Faster Trades & Easy Asset Management
Discover WEEX App’s new trading tabs: Futures, TradFi, Copy Trade (users)/ Elite Trade (lead traders) on the same page. Solve messy navigation, find opportunities faster, and manage all trades in one place.

WEEX All-New Search Features: Find, Trade & Earn Faster Than Ever
Supercharged search is here! Discover WEEX’s upgraded Search features with hot events, new listings, live market sentiment, and one-click trading. Trade smarter, seize every opportunity.

Morning Report | Illinois signs the strictest digital asset tax law in the U.S.; RWA tokenization market size surpasses $43 billion, institutions accelerate the migration of on-chain assets
Overview of Important Market Events on June 17

Full version of the debut Q&A! Federal Reserve Chairman Waller: Sticking to the 2% inflation target, establishing five special working groups, individual did not submit the dot plot
Federal Reserve Chairman Waller's debut featured a significant slimming statement, the cancellation of forward guidance, refusal to submit the dot plot, and the establishment of five working groups, vowing to uphold the 2% inflation target, which triggered a sharp decline in U.S. stocks and a surge ...

From Disruptor to Shadow Market: The Crypto Market is Becoming a Colony of Traditional Finance
"Coin-stock linkage" has evolved from the early stage of macro correlation and one-way penetration of emotional funds to the current 3.0 stage, where on-chain perpetual contracts provide extended trading hours and emotional signal value for traditional assets 24/7, and participate in Pre-IPO pricing...

Dalio's important long article: How to position in the current market environment?
Do not confuse the excitement for new technologies with whether those tech stocks are attractive.

OKX Star analyzes Binance's competitive advantages: when regulation levels the playing field, competition has just begun
OKX founder Star published a lengthy article, systematically analyzing Binance's competitive advantages over the years: regulatory arbitrage, speculative narrative cycles, social media control, and superficial compliance, stating that the essence of these advantages is not product capability, but ra...

New gameplay for participating in initial offerings on cryptocurrency exchanges
In this competition for cutting-edge assets, what has always been truly scarce is not the technology, but the underlying equity itself.

Why Is Bitcoin Down Today? What the Hawkish FOMC Means for SpaceX, Gold and Nasdaq
Why is Bitcoin down today? A hawkish FOMC pressured crypto and gold, while SpaceX surged to a $2.5 trillion valuation and Nasdaq gained attention. Here's what happened and why traders are looking beyond Bitcoin.

DeepSeek Financing Story
DeepSeek's financing insider information exposed: "Four-hour meeting" fully demonstrates Liang Wenfeng's determination for AGI, over a hundred institutions involved, Sequoia and Hillhouse rarely absent, not poaching talent is the hardest red line.
Stablecoins Finally Find Real Returns: On-Chain Reinsurance Re Explained | Interview with Re Founder Karan Saroya
This on-chain reinsurance platform absorbs stablecoins from DeFi, uses them as collateral to underwrite for American insurance companies, collects premiums, and returns the profits to on-chain depositors.
The AI gamble of mining companies: Valuations enter a phase of differentiation, and it's hard to turn the tide
This gamble of transforming into AI is testing the financial strength and execution capability of mining companies.
A letter from Alliance to entrepreneurs: Written on the occasion of Cursor selling for 60 billion dollars
Great companies are forged before they become obvious.
Will MicroStrategy fall into a death spiral? What will the macro trend be in the second half of the year?
The cryptocurrency industry may gradually shift from the hype of native altcoins to real asset tokenization, on-chain machine economy, and a more mature industrialization phase.
Blockchain Capital Partner: The Core Secret of Arbitrage
On cold starts, breaking the circle, and the toughest hurdle for founders to overcome.
STRC unanchored by 11%, can the perpetual motion machine of Strategy still operate?
Beyond the leverage crunch, what is even more concerning is the liquidity reserves of the Strategy.
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Program:support@weex.com

